Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Am J Respir Crit Care Med
1 Antimicrob Agents Chemother
1 Clin Infect Dis
1 Eur J Clin Microbiol Infect Dis
1 Eur Respir J
2 J Infect
6 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Respir Crit Care Med

    Coughing is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202204-0645.

  2. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202202-0259.
    PubMed         Abstract available

    Antimicrob Agents Chemother

  3. NUERMBERGER EL, Martinez-Martinez MS, Sanz O, Urones B, et al
    GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
    Antimicrob Agents Chemother. 2022 May 24:e0013222. doi: 10.1128/aac.00132.
    PubMed         Abstract available

    Clin Infect Dis

  4. CHOI H, Han K, Jung JH, Park SH, et al
    Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study.
    Clin Infect Dis. 2022 May 25. pii: 6591843. doi: 10.1093.
    PubMed         Abstract available

    Eur J Clin Microbiol Infect Dis

  5. MAO L, Xu L, Wang X, Du J, et al
    Use of DosR and Rpf antigens from Mycobacterium tuberculosis to screen for latent and relapse tuberculosis infection in a tuberculosis endemic community of Huainan City.
    Eur J Clin Microbiol Infect Dis. 2022 May 25. pii: 10.1007/s10096-022-04459.
    PubMed         Abstract available

    Eur Respir J

  6. MANTEI A, Meyer T, Schurmann M, Bessler C, et al
    Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease.
    Eur Respir J. 2022 May 26. pii: 13993003.01780-2021.
    PubMed         Abstract available

    J Infect

  7. BACHIR M, Guglielmetti L, Tunesi S, Billard-Pomares T, et al
    Molecular detection of isoniazid monoresistance improves tuberculosis treatment: a retrospective cohort in France.
    J Infect. 2022 May 20. pii: S0163-4453(22)00306.
    PubMed         Abstract available

  8. TUNESI S, Du DL, Gualano G, Millet JP, et al
    Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
    J Infect. 2022;84:834-872.

    PLoS One

  9. KATHAMUTHU GR, Sridhar R, Baskaran D, Babu S, et al
    Dominant expansion of CD4+, CD8+ T and NK cells expressing Th1/Tc1/Type 1 cytokines in culture-positive lymph node tuberculosis.
    PLoS One. 2022;17:e0269109.
    PubMed         Abstract available

  10. SAGHAZADEH A, Rezaei N
    Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268543.
    PubMed         Abstract available

  11. YANG DL, Li W, Pan MH, Su HX, et al
    Spatial analysis and influencing factors of pulmonary tuberculosis among students in Nanning, during 2012-2018.
    PLoS One. 2022;17:e0268472.
    PubMed         Abstract available

  12. READHEAD A, Flood J, Barry P
    Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014-2017.
    PLoS One. 2022;17:e0268739.
    PubMed         Abstract available

  13. BAKULA Z, Wuyep VB, Bartocha L, Vyazovaya A, et al
    Molecular snapshot of drug-resistant Mycobacterium tuberculosis strains from the Plateau State, Nigeria.
    PLoS One. 2022;17:e0266837.
    PubMed         Abstract available

  14. KHUNDI M, Carpenter JR, Corbett EL, Feasey HRA, et al
    Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.
    PLoS One. 2022;17:e0268749.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.